Amerikanische Gesellschaft für Hirudotherapie

Structure and cleavage pattern of a hyaluronate 3-glycanohydrolase in the glycoside hydrolase 79 family

Crystal structure paper published in Carbohydrate Polymers (2021)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genomik & ProteomikArzneimittelentwicklungHuang H et al. · Carbohydrate Polymers, 2021

Abstract

Hyaluronidases have attracted a great deal of interest in the field of medicine due to their fundamental roles in the breakdown of hyaluronan. However, little is known about the catalytic mechanism of the hyaluronate 3-glycanohydrolases. Here, we report the crystal structure and cleavage pattern of a leech hyaluronidase (LHyal), which hydrolyzes the β-1,3-glycosidic bonds of hyaluronan. LHyal exhibits the typical structural features of glycoside hydrolase 79 family but contains a variable 'exo-pocket' loop where basic residues R102 and K103 are the structural determinants of hyaluronan binding. Through analysis of the hydrolysis of even- and odd-numbered hyaluronan oligosaccharides, we demonstrate that hexasaccharide is the shortest natural substrate, which can be cleaved from both the reducing and non-reducing ends to release disaccharides, and pentasaccharides are the smallest fragments for recognition and hydrolysis. These observations provide new insights into the degradation of hyaluronan and the evolutionary relationships of the GH79 family enzymes.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsHyaluronic AcidHyaluronoglucosaminidaseHydrolysisLeechesModels, Molecular

Zusammenfassung

Crystal structure and cleavage pattern of leech hyaluronidase (LHyal), which hydrolyzes beta-1,3-glycosidic bonds of hyaluronan — establishing residues R102 and K103 as substrate-binding determinants in the GH79 family.

Warum dies für die Hirudotherapie relevant ist

This study reports the crystal structure and cleavage pattern of a leech hyaluronidase (LHyal), an enzyme in glycoside hydrolase family 79 that hydrolyzes β-1,3-glycosidic bonds of hyaluronan. The authors identified key structural determinants of hyaluronan binding (residues R102 and K103) and characterized minimum substrate sizes for recognition and hydrolysis, showing hexasaccharide as the shortest natural substrate. This work is relevant to understanding leech-produced enzymes and their biochemical roles. However, this is a structural/biochemical study with no therapeutic, pharmacological, or clinical data, and no direct connection to hirudotherapy practice is established.

Zitation

Structure and cleavage pattern of a hyaluronate 3-glycanohydrolase in the glycoside hydrolase 79 family.

Huang H et al. · Carbohydrate Polymers, 2021

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.